BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tomkin GH. Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. World J Diabetes 2014; 5(5): 636-650 [PMID: 25317241 DOI: 10.4239/wjd.v5.i5.636]
URL: https://www.wjgnet.com/1948-9358/full/v5/i5/636.htm
Number Citing Articles
1
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos E. Papadopoulos, Eleftherios Teperikidis, Michael Doumas, Vassilios Vassilikos. Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmiasActa Cardiologica 2023; 78(5): 519 doi: 10.1080/00015385.2022.2087839
2
Hyeong-Kyu Park, Rexford S. Ahima. Metabolic Syndrome2015; : 1 doi: 10.1007/978-3-319-12125-3_42-1
3
Verena B. Oliveira, Raquel L.B. Araújo, Thomas Eidenberger, Maria G.L. Brandão. Chemical composition and inhibitory activities on dipeptidyl peptidase IV and pancreatic lipase of two underutilized species from the Brazilian Savannah: Oxalis cordata A.St.-Hil. and Xylopia aromatica (Lam.) MartFood Research International 2018; 105: 989 doi: 10.1016/j.foodres.2017.11.079
4
Hyeong-Kyu Park, Rexford S. Ahima. Metabolic Syndrome2016; : 743 doi: 10.1007/978-3-319-11251-0_42
5
Kai-Jyun Chang, Jer-An Lin, Sheng-Yi Chen, Ming-Hung Weng, Gow-Chin Yen. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1Journal of Functional Foods 2019; 56: 136 doi: 10.1016/j.jff.2019.03.012
6
Tilo Moede, Ingo B. Leibiger, Per-Olof Berggren. Alpha cell regulation of beta cell functionDiabetologia 2020; 63(10): 2064 doi: 10.1007/s00125-020-05196-3
7
Helene Baribault. Mouse Models for Drug DiscoveryMethods in Molecular Biology 2016; 1438: 153 doi: 10.1007/978-1-4939-3661-8_10
8
Jean-Philippe Krieger, Wolfgang Langhans, Shin J. Lee. Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in ratsPhysiology & Behavior 2018; 192: 194 doi: 10.1016/j.physbeh.2018.03.037
9
Vasiliki Lagou, Longda Jiang, Anna Ulrich, Liudmila Zudina, Karla Sofia Gutiérrez González, Zhanna Balkhiyarova, Alessia Faggian, Jared G. Maina, Shiqian Chen, Petar V. Todorov, Sodbo Sharapov, Alessia David, Letizia Marullo, Reedik Mägi, Roxana-Maria Rujan, Emma Ahlqvist, Gudmar Thorleifsson, Ηe Gao, Εvangelos Εvangelou, Beben Benyamin, Robert A. Scott, Aaron Isaacs, Jing Hua Zhao, Sara M. Willems, Toby Johnson, Christian Gieger, Harald Grallert, Christa Meisinger, Martina Müller-Nurasyid, Rona J. Strawbridge, Anuj Goel, Denis Rybin, Eva Albrecht, Anne U. Jackson, Heather M. Stringham, Ivan R. Corrêa, Eric Farber-Eger, Valgerdur Steinthorsdottir, André G. Uitterlinden, Patricia B. Munroe, Morris J. Brown, Julian Schmidberger, Oddgeir Holmen, Barbara Thorand, Kristian Hveem, Tom Wilsgaard, Karen L. Mohlke, Zhe Wang, Marcel den Hoed, Aleksey Shmeliov, Marcel den Hoed, Ruth J. F. Loos, Wolfgang Kratzer, Mark Haenle, Wolfgang Koenig, Bernhard O. Boehm, Tricia M. Tan, Alejandra Tomas, Victoria Salem, Inês Barroso, Jaakko Tuomilehto, Michael Boehnke, Jose C. Florez, Anders Hamsten, Hugh Watkins, Inger Njølstad, H.-Erich Wichmann, Mark J. Caulfield, Kay-Tee Khaw, Cornelia M. van Duijn, Albert Hofman, Nicholas J. Wareham, Claudia Langenberg, John B. Whitfield, Nicholas G. Martin, Grant Montgomery, Chiara Scapoli, Ioanna Tzoulaki, Paul Elliott, Unnur Thorsteinsdottir, Kari Stefansson, Evan L. Brittain, Mark I. McCarthy, Philippe Froguel, Patrick M. Sexton, Denise Wootten, Leif Groop, Josée Dupuis, James B. Meigs, Giuseppe Deganutti, Ayse Demirkan, Tune H. Pers, Christopher A. Reynolds, Yurii S. Aulchenko, Marika A. Kaakinen, Ben Jones, Inga Prokopenko, Cornelia M. van Duijn. GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratificationNature Genetics 2023; 55(9): 1448 doi: 10.1038/s41588-023-01462-3
10
Tulika Arora, Udo Wegmann, Anup Bobhate, Ying Shiuan Lee, Thomas U. Greiner, Daniel J. Drucker, Arjan Narbad, Fredrik Bäckhed. Microbially produced glucagon-like peptide 1 improves glucose tolerance in miceMolecular Metabolism 2016; 5(8): 725 doi: 10.1016/j.molmet.2016.06.006
11
Anita Y H Lee, Derek L Chappell, Monika J Bak, Michael Judo, Linda Liang, Tatyana Churakova, Gulesi Ayanoglu, Jose Castro-Perez, Haihong Zhou, Stephen Previs, Sandra C Souza, Michael E Lassman, Omar F Laterza. Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance TestClinical Chemistry 2016; 62(1): 227 doi: 10.1373/clinchem.2015.244251
12
Mini P. Sajan, Barbara C. Hansen, Mildred Acevedo‐Duncan, Mark S. Kindy, Denise R. Cooper, Robert V. Farese. Roles of hepatic atypical protein kinase C hyperactivity and hyperinsulinemia in insulin‐resistant forms of obesity and type 2 diabetes mellitusMedComm 2021; 2(1): 3 doi: 10.1002/mco2.54
13
Catherine Arden. A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagyPeptides 2018; 100: 85 doi: 10.1016/j.peptides.2017.12.002
14
Jose Górriz, Javier Nieto, Juan Navarro-González, Pablo Molina, Alberto Martínez-Castelao, Luis Pallardó. Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data?Journal of Clinical Medicine 2015; 4(10): 1866 doi: 10.3390/jcm4101866
15
ОЦЕНКА ВЛИЯНИЯ ТЕРАПИИ ИНКРЕТИНОМИМЕТИКАМИ И ГЛИФЛОЗИНАМИ НА ФУНКЦИЮ АЛЬФА И БЕТА-КЛЕТОК ПОДЖЕЛУДОЧНОЙ ЖЕЛЕЗЫ У ПАЦИЕНТОВ С СД 2 ТИПА World Science 2021; (3(64)) doi: 10.31435/rsglobal_ws/30032021/7507
16
Jean Claude Mbanya, Saud Al-Sifri, Aly Abdel-Rahim, Ilhan Satman. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approachDiabetes Research and Clinical Practice 2015; 109(2): 226 doi: 10.1016/j.diabres.2015.04.030
17
Kyle S. Burger, Grace E. Shearrer, Jennifer R. Gilbert. Textbook of Energy Balance, Neuropeptide Hormones, and Neuroendocrine Function2018; : 347 doi: 10.1007/978-3-319-89506-2_13
18
Monica de Gaetano, Caitriona McEvoy, Darrell Andrews, Antonino Cacace, Jonathan Hunter, Eoin Brennan, Catherine Godson. Specialized Pro-resolving Lipid Mediators: Modulation of Diabetes-Associated Cardio-, Reno-, and Retino-Vascular ComplicationsFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01488
19
Josh Reed, Stephen Bain, Venkateswarlu Kanamarlapudi. A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future PerspectivesDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 3567 doi: 10.2147/DMSO.S319895